Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Clasificación en acciones #20402
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Precio por acción
$1.02
Capitalización bursátil
$131.45M
Cambio (1 día)
-0.62%
Cambio (1 año)
-37.92%
País
TW
Comercio Pharmosa Biopharm Inc. (6875)

Categoría

Historial del precio de la acción de Pharmosa Biopharm Inc. (6875)
Precio más alto de cierre: $1.04 el 2026-08-01

Precio más bajo de cierre: $1.60 el 2022-02-01
Historial del precio de la acción de Pharmosa Biopharm Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$548.44 38.80%
US
$1.03K 55.51%
NL
$119.27 -15.19%
AU
$765.51 8.31%
CH
$135.99 401.43%
US